Sen. Kennedy’s Foreign Inspection Bill Gives FDA More Flexibility Than House
Executive Summary
House and Senate Democrats are taking similar approaches in regard to invigorating FDA's ability to oversee foreign manufacturing facilities. But some fundamental differences and Republican concerns suggest that the issue will likely not be resolved until at least the next Congress
You may also be interested in...
Kennedy/Grassley Imports Criminal Liability To Global Drug Safety Efforts
A senior drug company officer or director would be required personally to certify the veracity of product applications and safety submissions to FDA, under Sens. Edward Kennedy, D-Mass., and Chuck Grassley's, R-Iowa, bill to improve safety in global drug manufacturing and distribution
Kennedy/Grassley Imports Criminal Liability To Global Drug Safety Efforts
A senior drug company officer or director would be required personally to certify the veracity of product applications and safety submissions to FDA, under Sens. Edward Kennedy, D-Mass., and Chuck Grassley's, R-Iowa, bill to improve safety in global drug manufacturing and distribution
FDA Chief Suggests Looking Outside Pharma For Tips On Quality Systems
FDA Commissioner Andrew von Eschenbach asked a group of medical products industry representatives July 9 to "think outside the box" to identify role models or lessons learned from other industries that could help address the challenges of drug import safety in a global marketplace